AFABILITY is pleased to announce that its application to join the European ECVAM Stakeholder Forum (ESTAF) has been approved. The ESTAF's roles are: -Advocacy, voicing of stakeholder interests (e.g. economical, societal, sectorial etc.) -Upstream input on relevance and applicability of proposed test methods and testing strategies -Communicating new activities, trends, scientific and technical issues; strategic…
Read more
29/07/16 – AFABILITY releases a new article in Science
AFABILITY's new article, Animal-based antibodies: Obsolete, by A. C. GRAY, S. S. SIDHU, P. C. CHANDRASEKERA, C. F. M. HENDRIKSEN, C. A. K. BORREBAECK was published in the prestigious journal of SCIENCE, 29 JUL 2016
Read more
25/07/16 – AFABILITY presents at the European Congress on Alternatives to Animal Testing in Linz, Austria
AFABILITY presented at the European Congress on Alternatives to Animal Testing, 24th-27th August 2016 , Linz, Austria. Click Here to see the published article.
Read more
20/07/16 – AFABILITY publishes a call for the replacement of animals in antibody production
In collaboration with Lund University, Sweden, University of Toronto, Canada and Institute of veterinary sciences, Netherlands, AFABILITY is proud to announce the release of a new open access article, Animal friendly affinity reagents - replacing the needless in the haystack, in the journal Trends in Biotechnology
Read more
- 1
- 2